Related Experiment Video
Updated: May 26, 2026
Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
Published on: April 17, 2017
Spinal muscular atrophy type 1: are proactive respiratory interventions associated with longer survival?
Tara J Lemoine1, Kathryn J Swoboda, Susan L Bratton
1Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA. lemoine@hsc.utah.edu
Insights
Early noninvasive respiratory interventions in spinal muscular atrophy type 1 (SMA1) are linked to longer survival. Proactive respiratory care for SMA1 patients demonstrated improved survival outcomes compared to supportive care alone.
Area of Science:
- Pediatric Neurology
- Genetics
- Respiratory Medicine
Background:
- Spinal muscular atrophy type 1 (SMA1) is a severe genetic disorder.
- It is a primary cause of infant mortality.
- Early diagnosis and intervention are critical for managing SMA1.
Purpose of the Study:
- To evaluate the association between early noninvasive respiratory support and survival in SMA1 patients.
- To compare outcomes between proactive and supportive respiratory care strategies.
Main Methods:
- Retrospective cohort study of 49 SMA1 patients.
- Patients were grouped into proactive (n=26) or supportive (n=23) respiratory care within 3 months of diagnosis.
- Interventions included bilevel noninvasive ventilation and cough assist for proactive care; suctioning and oxygen for supportive care.
Main Results:
- Early proactive respiratory care was associated with statistically longer survival (log rank 0.047).
- Patients receiving proactive care had increased hospitalizations for respiratory insufficiency (83% vs. 46%).
- Time to first hospitalization for respiratory insufficiency was shorter in the proactive group (median 118 vs. 979 days).
Conclusions:
- Early initiation of noninvasive respiratory interventions is associated with improved survival in SMA1.
- Proactive respiratory support strategies warrant consideration for managing SMA1.
- Further research may clarify optimal timing and methods for respiratory support in SMA1.
Context:
Spinal muscular atrophy type 1, an autosomal recessive motor neuron disease, is a leading genetic cause of death in infancy and early childhood.
Objective:
To determine whether the early initiation of noninvasive respiratory interventions is associated with longer survival.
Design:
Single-institution retrospective cohort study identified children with spinal muscular atrophy type 1 from January 1, 2002 to May 1, 2009 who were followed for 2.3 mean yrs.
Setting:
Tertiary care children's hospital and outpatient clinics in a vertically integrated healthcare system.
Patients Or Other Participants:
Forty-nine children with spinal muscular atrophy type 1 were grouped according to the level of respiratory support their caregivers chose within the first 3 months after diagnosis: proactive respiratory care (n = 26) and supportive care (n = 23).
Interventions:
Proactive respiratory care included bilevel noninvasive ventilation during sleep and twice a day cough assist while supportive respiratory care included suctioning, with or without supplemental oxygen.
Measurements And Main Results:
Kaplan-Meier survival curves were assessed based on intention to treat. Children treated with early proactive respiratory support had statistically longer survival compared to supportive care (log rank 0.047); however, the adjusted hazard ratio for survival was not statistically different (2.44 [95% confidence interval 0.84-7.1]). Children in the proactive group were more likely to be hospitalized for respiratory insufficiency (83% vs. 46%) and had shortened time after diagnosis until first hospital admission for respiratory insufficiency (median 118 vs. 979 days).
Conclusion:
Longer survival time with spinal muscular atrophy type 1 is associated with early, noninvasive respiratory care interventions after diagnosis.
Related Concept Videos
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment